PH12018000390A1 - Carbocysteine and zinc tablet - Google Patents

Carbocysteine and zinc tablet

Info

Publication number
PH12018000390A1
PH12018000390A1 PH12018000390A PH12018000390A PH12018000390A1 PH 12018000390 A1 PH12018000390 A1 PH 12018000390A1 PH 12018000390 A PH12018000390 A PH 12018000390A PH 12018000390 A PH12018000390 A PH 12018000390A PH 12018000390 A1 PH12018000390 A1 PH 12018000390A1
Authority
PH
Philippines
Prior art keywords
carbocysteine
zinc
tablet
zinc tablet
less
Prior art date
Application number
PH12018000390A
Inventor
Ellen V Herrera
Joyce Bedelia B Santos
Kennie U Dee
Original Assignee
Novex Science Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novex Science Pte Ltd filed Critical Novex Science Pte Ltd
Priority to PH12018000390A priority Critical patent/PH12018000390A1/en
Priority to PCT/IB2019/050062 priority patent/WO2020104855A1/en
Publication of PH12018000390A1 publication Critical patent/PH12018000390A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to a tablet containing not less than 500-mg of carbocysteine and 3-10 mg of elemental zinc, characterized by fast disintegration, low friability, and good manufacturability.
PH12018000390A 2018-11-20 2018-11-20 Carbocysteine and zinc tablet PH12018000390A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PH12018000390A PH12018000390A1 (en) 2018-11-20 2018-11-20 Carbocysteine and zinc tablet
PCT/IB2019/050062 WO2020104855A1 (en) 2018-11-20 2019-01-04 Carbocysteine and zinc tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PH12018000390A PH12018000390A1 (en) 2018-11-20 2018-11-20 Carbocysteine and zinc tablet

Publications (1)

Publication Number Publication Date
PH12018000390A1 true PH12018000390A1 (en) 2020-09-28

Family

ID=70773350

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12018000390A PH12018000390A1 (en) 2018-11-20 2018-11-20 Carbocysteine and zinc tablet

Country Status (2)

Country Link
PH (1) PH12018000390A1 (en)
WO (1) WO2020104855A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8502092A (en) * 1985-07-22 1987-02-16 Cedona Haarlemmer Pharma TABLETS CONTAINING S-CARBOXYMETHYLCYSTEINE AND METHOD FOR THE PREPARATION THEREOF
DK0481294T4 (en) * 1990-10-19 2001-06-18 Spirig Ag Solid, fast-soluble drug preparation containing N-acetylcysteine
TW442301B (en) * 1995-06-07 2001-06-23 Sanofi Synthelabo Pharmaceutical compositions containing irbesartan
CN103271900B (en) * 2013-05-31 2014-12-17 河南创新药业有限公司 Zinc citrate tablet and preparation method thereof
JP6320107B2 (en) * 2014-03-26 2018-05-09 杏林製薬株式会社 Orally disintegrating tablets
CN104161746B (en) * 2014-09-10 2016-10-26 郑敬操 Sugarless type Lysinepuzinc particulate composition and preparation method

Also Published As

Publication number Publication date
WO2020104855A1 (en) 2020-05-28

Similar Documents

Publication Publication Date Title
PH12018500047B1 (en) Notch pathway signaling inhibitor compounds
MX2020009146A (en) Anodes containing spherical powder and capacitors.
GB2544421A (en) Degradable downhole tools comprising magnesium alloysª
MY198202A (en) Container containing a nicotine solution
MX2022003859A (en) Treatment of retinitis pigmentosa.
MX2016015092A (en) Cancer stem cell proliferation inhibitor.
MX2019015676A (en) Use of isovalerylspiramycin i, ii and/or iii in preparation of drug for treating and/or preventing tumour, and drug.
PH12020550567A1 (en) Ring-fused thiazolino 2-pyridones in combination with a drug against tuberculosis
TR201916829A2 (en) DUAL-LAYER TABLET FORMULATIONS CONTAINING DAPAGLYFLOZIN AND METFORMIN
MX2019010950A (en) Phenalene-1-one-containing photosensitizer composition, phenalene-1-one compound and the use thereof.
ZA202006377B (en) Boronic acid derivatives and therapeutic uses thereof
MX2020002310A (en) High concentration dosage forms of pridopidine.
MX2019010330A (en) Formulations with improved stability.
MX369506B (en) Metal salt compositions.
EA033314B1 (en) ANTIBACTERIALS COMPRISING PYRAZINO[2,3-b][1,4]OXAZIN-3-ONE OR A RELATED RING SYSTEM
GEP20237486B (en) Formulations of copanlisib
PH12018500791B1 (en) Stable composition of vitamin c and zinc tablet
PH12018000390A1 (en) Carbocysteine and zinc tablet
EA201891886A1 (en) CONTAINING PREGABALIN A THREE-LAYER TABLET WITH SLOW-RELEASE EXTRACTION FOR ORAL RECEPTION
SG11201900713XA (en) Method of preparing coal ash
EA201691422A1 (en) ORIGINALLY FALLING TABLETED MEMANTINE COMPOSITIONS
PH12015500469A1 (en) High dose extended-release potassium citrate wax matrix tablet
MX2020000104A (en) Water stable granules and tablets.
WO2019059868A3 (en) Pharmaceutical combinations comprising tenofovir, emtricitabine and efavirenz
SG10201809621XA (en) Plate